HOME >> BIOLOGY >> NEWS
A low expression of MX2 gene exists in the white blood cells of narcoleptics

WESTCHESTER, Ill. -- The first report to identify the biological markers of narcolepsy using gene expression in white blood cells finds that the MX2 gene, which is relevant to the immune system, is significantly less expressed in narcoleptics compared with normal subjects. This underlies the abnormalities in the blood cells of persons suffering from narcolepsy, according to a study published in the August 1st issue of the journal SLEEP.

Susumu Tanaka, PhD, of the Tokyo Institute of Psychiatry in Japan, conducted the study from a pool of total ribonucleic acid (RNA) a nucleic acid polymer that plays several important roles in the processes that translate genetic information from DNA into protein products from 12 patients with narcolepsy with cataplexy and from 12 age- and sex-matched healthy controls. The pooled samples were initially screened for candidate genes for narcolepsy by differential display analysis using annealing control primers (ACP).

The second screening of the samples was carried out by semiquantitative polymerase chain reaction (PCR) a biochemistry and molecular biology technique for isolating and exponentially amplifying a fragment or sequence of interest of DNA, via enzymatic replication, without using a living organism using gene-specific primers.

Finally, the expression levels of the candidate genes were further confirmed by quantitative real-time PCR using a new set of samples: 20 patients with narcolepsy with cataplexy and 20 healthy controls.

According to the study, the second screening revealed differential expression of four candidate genes, among which MX2 was confirmed as a significantly down-regulated gene in the white blood cells of narcoleptic patients by quantitative real-time PCR.

In narcolepsy, it has been suggested that specific alterations in the immune system occur, and its important for pathophysiology of this disorder, said Tanaka. We thought that
'"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
1-Aug-2007


Page: 1 2

Related biology news :

1. Gene expression pattern could lead to improved treatment of pediatric septic shock
2. Boston Univeristy bioengineers devise dimmer swith to regulate gene expression in mammal cells
3. Clocking in and out of gene expression
4. High cholesterol diets modify gene expression in atherosclerosis
5. Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients
6. Decoding gene expression in cancer tumors using noninvasive imaging
7. Growing nerve cells in 3-D dramatically affects gene expression
8. XDx to present recent success with AlloMap molecular expression testing
9. Fat tissue-derived hormone leptin increases e-cadherin expression, obesity-breast cancer link noted
10. Clues to gene expression in cystic fibrosis will guide research
11. Protein overexpression at heart of heart failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2019)... Mass. (PRWEB) , ... January 20, 2019 , ... Energetiq ... its parent company, Hamamatsu Photonics, at the SPIE BIOS and SPIE Photonics West events ... and Hamamatsu will be in booth #8526 at Bios and in booth #941 at ...
(Date:1/20/2019)... ... January 16, 2019 , ... January has been a record-breaking month ... Not only has the company already hosted several of its signature cooking classes and ... and Janssen Pharmaceuticals, later this month. , Since 2008, Lajollacooks4u’s team-building events have ...
(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , ... in blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in ... The results from this study show CellMax Life’s blood test, based on its ...
Breaking Biology News(10 mins):
(Date:2/2/2019)... ... January 31, 2019 , ... ... clinical use of perinatal tissue by applied stem cell research expert and Amazon ... Signature Cord is a flowable umbilical cord tissue allograft that originates from the ...
(Date:1/30/2019)... ... January 29, 2019 , ... Actus Therapeutics, a ... of the first patient in a phase 1/2 clinical study of ACTUS-101 in ... high morbidity and often leads to premature death. There are variable rates ...
(Date:1/30/2019)... ... January 30, 2019 , ... In ... tasting 5StarWines to promote and give recognition to producers whose work focuses entirely ... selection takes place in Verona, Italy, contemporaneously to the 5StarWines blind tasting organized ...
(Date:1/24/2019)... , ... January 23, 2019 , ... ... microbial genomics, has awarded microbiome research support in study design, planning, sample collection, ... of Medical Sciences, St. Augustine Campus in Trinidad led by Dr. Elaine Monica ...
Breaking Biology Technology:
Cached News: